Eton Pharmaceuticals, Inc.
ETON · Healthcare · $1.4B
$51.49-13.01%
Price
$37.50
$59.19
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$42M+11.7%
6/'26 vs prev quarter
Company Health
Market Cap$1.4B
Operating Margin+15.4%
Cash on Hand$27M1.9% of market cap
Free Cash Flow$15M1.0% of market cap
Short Float 7.4% · biweekly · settled 26.05.15
Among 60 Drug Manufacturers - Specialty & Generic peers
LowMedianHigh
PSR13.4xmedian 1.7xPER111.2xmedian 15.6xPBR30.3xmedian 1.4xROE+27.2%median -4.2%Connor Clark & Lunn Investment Management Ltd. Makes New $476,000 Investment in Eton Pharmaceuticals, Inc. $ETONSep 2
BlackRock Inc. Invests $68.63 Million in Eton Pharmaceuticals, Inc. $ETONAug 31
Eton Pharmaceuticals, Inc. $ETON Stock Holdings Increased by Bank of America Corp DEAug 30
Bank of Nova Scotia Acquires New Position in Eton Pharmaceuticals, Inc. $ETONAug 28
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare ConferenceAug 27
Why Eton Pharmaceuticals Is Top of the Class TodayAug 14
